发明名称 Caffeine and N-methyl-2-[2'(alpha-methyl-p-chloro-benzhydryl-oxy)ethyl]-pyrrolidine or N-methyl-2-[2'(alpha-methyl-p-bromo-benzhydryl-oxy)ethyl]-pyrrolidine
摘要 A composition for the treatment, management or mitigation of cold, cold-like, allergy, sinus and/or flu symptoms by administering a safe and effective amount of a composition comprising caffeine and certain pyrrolidine and piperidine ether antihistaminic agents. The preferred pyrrolidine or piperidine ether antihistaminic agent is shown in the formula described. Wherein: R1 is a radical selected from H, halogen, C1-4alkyl or C1-4alkoxy; R2 is a radical selected from C1-4alkyl; m is an integer from 0-3; and n is and integer from 1-2. The composition further comprises of propionic acid derivative selected from ibuprofen, naproxen, benoxaprofen, flurbiprofen, ketoprofen, fenoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen and tiaprofen.
申请公布号 NZ331575(A) 申请公布日期 2000.06.23
申请号 NZ19970331575 申请日期 1997.03.05
申请人 THE PROCTER & GAMBLE COMPANY 发明人 MITRA, SEKHAR
分类号 A61K31/435;A61K31/00;A61K31/40;A61K31/402;A61K31/52;A61P31/00;A61P31/16;A61P37/00;A61P37/08;(IPC1-7):A61K31/40;A61K31/135;A61K31/485;A61K31/445 主分类号 A61K31/435
代理机构 代理人
主权项
地址